logo

Inflarx N.V. (IFRX)



Trade IFRX now with
  Date
  Headline
8/10/2021 9:28:34 AM InflaRx Announces Positive Data From Second Interim Analysis Of Phase IIa Open Label Study With Vilobelimab In PG
6/8/2021 7:36:45 AM InflaRx Enrolls First Patient In Multicenter Phase II Trial In Cutaneous Squamous Cell Carcinoma With Vilobelimab
5/21/2021 8:01:59 AM InflaRx Names Tony Gibney Non-Executive Director To Board
1/5/2021 7:37:01 AM InflaRx Completes Enrollment In Vilobelimab European Phase II Study In ANCA-associated Vasculitis
9/14/2020 7:59:11 AM InflaRx Initiates Phase III Part Of Phase II/III Clinical Trial With IFX-1
2/26/2020 7:52:41 AM InflaRx Announces Positive Initial Data From Phase IIa Open Label Study With IFX-1 In Patients Suffering From PG